HD-OPM Archive
Topics › Heart rhythm & heart failure

mRNA-driven Myc and Cyclin T1 restarted heart muscle cell division after heart attack

Louis Nervegna · Nov 14, 2026 · ♥ 2 reactions · 0 comments · original Facebook post
Heart rhythm & heart failureHeart attack, stroke & procedures
AI summary & key facts

Louis shares a summary of a Nature Cardiovascular Research study from Cambridge using temporary modified mRNA to activate Myc and Cyclin T1 in heart muscle cells so mature cardiomyocytes re-enter division. The aim is to regenerate heart tissue after a heart attack instead of leaving scar tissue and chronic heart failure. This is early-stage regeneration research.

Link to journal paper:

Paper · Nat Cardiovasc Res · 2026A transient modified mRNA encoding Myc and cyclin T1 improves cardiac function after myocardial injuryMyc is an evolutionarily conserved transcription factor that is necessary for the restoration of tissues in multiple regenerative species. The adult mammalian heart lacks regenerative capacity and cardiomyocytes fail to divide following damage-induced signaling. Transgenic expression of Myc and cyclin T1 can drive substantial adult cardiomyocyte proliferation to replace lost cardiomyocytes. Here, using transgenic…nature.com

#heartfailureHD #mrnaHD #mycHD #cyclint1HD

Research cited

Reawakening the Heart: A Breakthrough in Heart Attack Recovery

Imagine if your heart could heal itself after a heart attack just like a scraped knee heals over time. For decades, medical science has faced a harsh biological reality: once adult human heart muscle cells (cardiomyocytes) mature, they lose their ability to divide and multiply. When a heart attack strikes, those starved cells die, leaving behind rigid scar tissue that permanently weakens the heart and frequently leads to chronic heart failure.
//www.nature.com/articles/s44161-026-00910-7

However, a groundbreaking study published in Nature Cardiovascular Research by researchers at the University of Cambridge changes the narrative, demonstrating that it may be possible to coax damaged heart tissue back to life.

The Secret: A Temporary Genetic "Wake-Up Call"

The research team utilized messenger RNA (mRNA) technology—the same versatile platform utilized in modern vaccines—to deliver a short-lived instruction manual directly to the heart.

Rather than permanently editing a patient's DNA, the treatment introduces modified mRNA that temporarily activates two key proteins inside the heart cells: Myc and Cyclin T1.

Promising Results in Pre-Clinical Tests

When researchers tested this transient mRNA therapy on mice recovering from myocardial injuries (heart attacks), the results were compelling:

Looking Ahead to Human Medicine

While these findings are still at an early pre-clinical stage, they represent a monumental conceptual shift in cardiology. Moving forward, researchers will need to test the safety and effectiveness of the therapy in larger animal models before human clinical trials can begin. If successful, this approach could eventually shift heart attack treatment from merely managing long-term decline to true cellular regeneration.

#RegenerativeMedicine #CardiologyResearch #HeartHealth

May be an image of text
← newer: Joel Kahn: three new studies suggest no rush for bypass or solder: YELLOW-III: statin plus PCSK9 inhibitor thickened fibrous ca →